Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Fig. 2

Multistate model results for expected ICU stay and hospital stay up to 90 days from hospital admission. A all included patients (n = 737); B ACEi/ARB group; and C Non-ACEi/ARB group. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, CI confidence intervals, ICU intensive care unit. Estimated probabilities at day 0 represent the proportions of patients admitted to ICU on the same day as hospital admission, and the patients who were admitted to the general ward prior to being transferred to the ICU at a later date during hospitalization

Back to article page